Impact of age on cardiovascular risk: implications for cardiovascular disease management

Jaakko Tuomilehto1

  • 1National Public Health Institute, University of Helsinki, Mannerheiminite 166, 00300 Helsinki, Finland. jaakko.tuomilehto@ktl.fi

Insights

Cardiovascular disease (CVD) risk increases with age, driven by metabolic factors like smoking, dyslipidemia, hypertension, and type 2 diabetes. Management strategies must consider age-related changes for effective prevention and treatment.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a significant global health concern with increasing prevalence in aging populations worldwide.
  • The growing elderly demographic presents challenges for effective cardiac and cerebrovascular disease prevention and management.
  • Established risk factors include smoking, dyslipidemia, hypertension, and type 2 diabetes.

Purpose of the Study:

  • To review the evidence linking key metabolic risk factors to cardiovascular complications.
  • To assess how the risk of these complications changes with advancing age.
  • To evaluate optimal management strategies for these conditions and their age-related treatment outcomes.

Main Methods:

  • Systematic review of existing scientific literature.
  • Analysis of epidemiological data on cardiovascular disease prevalence and risk factors across age groups.
  • Evaluation of clinical guidelines and research on the management of metabolic risk factors in older adults.

Main Results:

  • Metabolic risk factors significantly elevate the risk of cardiac and cerebrovascular events, with risk often increasing with age.
  • Age influences the presentation and progression of cardiovascular disease and its associated risk factors.
  • Treatment outcomes for hypertension, dyslipidemia, and diabetes may be affected by patient age, necessitating tailored approaches.

Conclusions:

  • Effective cardiovascular disease prevention and management in aging populations requires a comprehensive understanding of age-related risk factor modification.
  • Optimizing treatment strategies based on age is crucial for improving patient outcomes and reducing the burden of cardiovascular disease.
  • Further research is needed to address unresolved issues in the age-specific management of cardiovascular risk factors.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...